GRAHASRX PHARMACEUTICAL PRIVATE LIMITED
Sectors as filed: Pharmaceutical
Something wrong with this record?
Six things we look for on every record: DPIIT recognition, a CIN, a website, a description, a logo and a funding signal. Not held here: Website and Funding signal.
Where this is
District
Delhi
Delhi
Startup India records the district. We do not have a street address for this company, and we will not invent one.
No point is drawn, because we do not have one.
Geocode confidence: medium
What this record amounts to
GRAHASRX PHARMACEUTICAL PRIVATE LIMITED is a Startup India record we can place no finer than Delhi district, which holds 43,654 records in this snapshot. 3,911 of those records are filed under Healthcare & Lifesciences, 9% of the district. It carries no funding signal of any class, which is true of 39,426 of the 43,654 records in Delhi.
Every figure above is counted from the 2026-08 snapshot and is the same number the page it links to prints.
In their own words
Our business is involved in the production, distribution, and export of high-quality medicines which have been approved by the United States Food and Drug Administration (USFDA). We primarily cater to emerging markets around the world, where access to safe and effective medications is often limited. Ensuring the highest level of quality standards, our medicines undergo a rigorous regulatory approval process set by the USFDA. This includes extensive testing and documentation to prove their safety, efficacy, and consistent quality. By meeting USFDA standards, we are able to provide assurance to our customers in emerging markets that they are receiving medicines that adhere to stringent regulatory requirements. Our product portfolio covers a wide range of therapeutic areas, including but not limited to cardiovascular, respiratory, infectious diseases, and oncology. We constantly strive to expand our range to address the diverse healthcare needs of the emerging markets we serve. In addition to manufacturing, we have established a robust distribution network that ensures seamless and timely availability of our medicines to healthcare providers and patients in these markets. We prioritize quality control measures throughout the supply chain to maintain product integrity and ensure patient safety. The mission of our business is to bridge the healthcare gap in emerging markets by delivering USFDA quality medicines. We believe that everyone should have access to safe and effective treatments, regardless of their geographic location or income level. By leveraging our expertise, regulatory compliance, and global reach, we aim to improve healthcare outcomes and contribute to the overall well-being of communities in these markets.
Written by the company on its public Startup India profile. Not verified by us.
What the record says
- DPIIT recognition number
- DIPP175102
- CIN
- U21002DL2024PTC432610
- Registered on Startup India
- 2024
- Self-declared stage
- Prototype
- Industry
- Healthcare & Lifesciences
- Healthcare & Lifesciences in Delhi
- 3,911 records
- District
- Delhi
- State
- Delhi
The neighbourhood
This record carries no locality line, so the district is the finest ring we can place it in.
What we do not know
- no website on file
- no incorporation date
- no funding signal of any kind
- no address beyond the district
We have no liveness signal for any company on this site: no filings feed, no revenue, no check that the website still resolves. A record existing here means a record exists, not that a business is trading.
Is this your company?
Everything here comes from public government records. If something is wrong, the authoritative place to correct it is the Startup India portal itself, and we will pick the correction up on the next monthly snapshot. To flag an error on our side, use the report link or write to trust@indianstartupmap.com.
How we built this record Where the data comes from How you may reuse it
Keep looking
One record is one row. Delhi has 43,654.
See Delhi